Drug Regulatory Authority of Pakistan makes a massive cut in the prices of Remdesivir drug
Shares
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) notified on Thursday a Rs3,564 cut in the price of Remdesivir, a drug found to be effective in treating patients hospitalised with coronavirus.
According to the notification, the new price of 100mg vial of the antiviral is fixed at Rs5,680.
The drug regulator has asked firms importing Remesivir to mention the drug price on its packet.
On November 27, the federal cabinet had green-lighted a cut in the price link of the antiviral.
